低密度脂蛋白通过增强·维勒布兰德因子自我关联来促进微血管血栓形成
Dominic W Chung1,2, Kimsey Platten3, Koya Ozawa4
1Bloodworks Research Institute, Seattle, WA.
Blood
|July 28, 2023
概括
低密度脂蛋白 (LDL) 促进威尔布兰德因子 (VWF) 的自我结合和沉积,增加血栓形成的风险. 高密度脂蛋白 (HDL) 抵消了这种效应,这表明在治疗血栓性疾病方面具有治疗潜力.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 心血管科学 心血管科学
背景情况:
- ·威尔布兰德因子 (VWF) 在剪切应力下对初级静血和血栓形成至关重要.
- 之前已经表明,高密度脂蛋白 (HDL) 和无脂蛋白AI可以减弱VWF自我关联.
- 低密度脂蛋白 (LDL) 在剪切下的VWF行为中的作用尚不清楚.
研究的目的:
- 在水力动力学力下研究LDL和VWF之间的相互作用.
- 为了确定LDL如何影响VWF自我结合和沉积.
- 为了评估LDL-HDL比率对体外和体内体外VWF介导的血栓形成的影响.
主要方法:
- 使用纯化的VWF和等离子体进行和微流体测试.
- 在不同的脂蛋白度下评估VWF沉积和丝状形成.
- 在体内研究使用Adamts13-/- 和LDLR-/-小鼠,以及野生型小鼠的LDL水平发生变化.
主要成果:
- 在剪切下,LDL与VWF结合,增强其自我结合和沉积.
- LDL与HDL的比率,而不是绝对度,与增加的VWF损失和沉积相关.
- 在体内,高的LDL水平加剧了VWF-血小板粘附,心脏功能降低,血栓大小和持久性增加.
结论:
- LDL促进VWF的自我结合和沉积,有助于发生血栓事件.
- LDL与HDL的比率是VWF介导的血栓形成的一个关键决定因素.
- 向VWF-LDL相互作用可能为血栓性微血管病变和动脉样硬化提供治疗策略.
更多相关视频
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
9.0K
05:12Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice
Published on: August 13, 2015
12.6K
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
755
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
755
Venous Thrombosis I: Introduction
13
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
13
Coronary Artery Disease II: Pathophysiology
13
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
13
Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K
Atherosclerosis I: Introduction
11
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
Disorders of Hemostasis
992
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
992
